The glaucoma treatments market is expected to increase to a value of US$ 6.9 million by 2022. Between 2022 and 2032, the total demand for glaucoma medicines is expected to grow at a compound annual growth rate (CAGR) of 3.7%, or approximately US$ 10.2 million.
By treatment type, medication eye drops segment will hold the maximum market share for the global glaucoma therapeutic market due to its high preference by the physician for medication during the early stages of treatment.
Laser surgery is more preferred than tradition surgery by booth surgeon and the patients owing to the low risk of failure. By glaucoma type, closed glaucoma will dominate the maximum market share attributed to its more prevalence then open glaucoma.
Get a Sample Copy of the Report :
https://www.futuremarketinsights.com/reports/sample/rep-gb-6456
Glaucoma Therapeutics Market: Drivers and Restraints:
The change in the lifestyle of people has resulted in the rise in the prevalence of glaucoma globally. Increasing prevalence of glaucoma is the primary factor driving the growth of glaucoma therapeutics market around the globe. Glaucoma is more prevalent among the people above the age of 60. Rising geriatric population thought the globe is also responsible for the robust growth of glaucoma therapeutics market over the forecast period. Increasing preference of physician towards the laser surgery for the treatment of glaucoma will propel the growth of glaucoma therapeutics market over the forecast period.
Less awareness among the people about the glaucoma treatment will deter the growth of glaucoma therapeutics market to some extent. Moreover, lack of availability of skilled professional for laser surgery in under developing economies will also hamper the growth of glaucoma therapeutics market. Glaucoma is the eye disease that damage the patient eye nerve optics. The formation extra fluid up in the front part of the eye results the damage to eye nerve optics. Glaucoma is of two type, primary open-angle glaucoma and angle-closure glaucoma which is also referred as closed-angle glaucoma or narrow-angle glaucoma.
Open-angle glaucoma is the most common type glaucoma. Primary glaucoma gradually happens when the eye does not drain the fluids.
This result the building of pressure on eye nerve optics. Open glaucoma causes no change in the eye vision and it is painless too.
Closed-angle glaucoma happens very close to the drainage angle which results the blocking of drainage angle of eyesight. This is a very acute type of glaucoma.
This type of glaucoma may affect the vision of the patient and it may cause severe pain to the eye and the headache.
Glaucoma is generally treated with eye drops, pill, traditional surgery, laser surgery and sometimes the combination of these methods.
The aim of glaucoma treatment is to avoid the vision loss of patient wherever if the vision of particular patient is already lost then it is irreversible by glaucoma treatment.
Elevate Strategy: Tap into Analyst Expertise Now:
https://www.futuremarketinsights.com/ask-question/rep-gb-6456
Regular consumption of medication as prescribed by the physician is very necessary for the proper treatment of glaucoma.
The drugs of glaucoma have very fewer chances of effects which has increased it adoption the global market.
Glaucoma Therapeutics Market: Key Players
Some of player across the value chain of Glaucoma Therapeutics market are Novartis AG, Allergan, Merck & Co., Inc., Akorn, Inc., Bausch & Lomb Incorporated, Teva Pharmaceuticals, Pfizer and Santen and others.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.
It also contains projections using a suitable set of assumptions and methodologies.
The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report covers exhaust analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
Regional analysis includes:
- North America (U.S., Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany, Italy, France, U.K, Spain)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, ASEAN, Australia & New Zealand)
- Japan
- Middle East and Africa (GCC Countries, S. Africa, Northern Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Unleash Potential: Craft Your Customized Report Now:
https://www.futuremarketinsights.com/customization-available/rep-gb-6456
Glaucoma Therapeutics Market: Segmentation
The global Glaucoma Therapeutics market is classified on the basis of treatment type, glaucoma type, and geographic region.
Based on treatment type, Glaucoma Therapeutics market is segmented into following:
- Eye Drops
- Medication
- Laser Surgery
- Traditional Surgery
Based on glaucoma type, Glaucoma Therapeutics market is segmented into following:
- Open-angle glaucoma
- Closed-angle glaucoma
Key Segments:
Glaucoma Therapeutics Market by Treatment Type:
- Eye Drops Glaucoma Therapeutics
- Medication Glaucoma Therapeutics
- Laser Surgery Glaucoma Therapeutics
- Traditional Surgery Glaucoma Therapeutics
Glaucoma Therapeutics Market by Glaucoma Type:
- Open-Angle Glaucoma Therapeutics
- Closed Angle Glaucoma Therapeutics
Glaucoma Therapeutics Market by Region:
- North America Glaucoma Therapeutics Market
- Latin America Glaucoma Therapeutics Market
- Europe Glaucoma Therapeutics Market
- Asia Pacific Glaucoma Therapeutics Market
- Middle East & Africa Glaucoma Therapeutics Market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube